Abstract
The first synthesis of 1'-C-CN, 2'-F, 2'-C-Me pyrimidines is described. Anti-HCV activity was assessed and compared to the 1'-C-CN, 2'-C-Me as well as the 2'-F, 2'-C-Me pyrimidines. A phosphoramidate prodrug of the cytidine derivative showed activity in the low micromolar range against HCV replicons.
Keywords:
HCV antivirals; Nucleotide phosphoramidate prodrugs; Pyrimidine nucleoside analogs.
Copyright © 2015 Elsevier Ltd. All rights reserved.
MeSH terms
-
Amides / chemistry
-
Amides / pharmacology
-
Antiviral Agents / chemistry*
-
Antiviral Agents / pharmacology*
-
Cell Line
-
Halogenation
-
Hepacivirus / drug effects*
-
Hepacivirus / enzymology
-
Hepatitis C / drug therapy
-
Hepatitis C / virology
-
Humans
-
Methylation
-
Phosphoric Acids / chemistry
-
Phosphoric Acids / pharmacology
-
Prodrugs / chemistry
-
Prodrugs / pharmacology
-
Pyrimidine Nucleosides / chemistry*
-
Pyrimidine Nucleosides / pharmacology*
-
RNA-Dependent RNA Polymerase / antagonists & inhibitors
-
Replicon / drug effects
Substances
-
Amides
-
Antiviral Agents
-
Phosphoric Acids
-
Prodrugs
-
Pyrimidine Nucleosides
-
phosphoramidic acid
-
RNA-Dependent RNA Polymerase